U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188901188901Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple SclerosisCompletedNo Results AvailableRelapsing-remitting Multiple SclerosisDrug: Human interferon beta-1a and glatiramer acetatehttps://ClinicalTrials.gov/show/NCT00078338
188902188902Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)CompletedHas ResultsObstructive Sleep Apnea|HypopneaDrug: Armodafinil 250 mg/day|Drug: Armodafinil 150 mg/day|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00078325
188903188903Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep DisorderCompletedHas ResultsNarcolepsy|Sleep Apnea, Obstructive|Sleep Apnea Syndromes|Shift-Work Sleep DisorderDrug: CEP-10953 (Armodafinil)https://ClinicalTrials.gov/show/NCT00078312
188904188904Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading SystemCompletedNo Results AvailableCataracthttps://ClinicalTrials.gov/show/NCT00078299
188905188905Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart FailureCompletedHas ResultsHeart Failure, Congestive|Chronic Heart Failure|DepressionDrug: Sertraline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00078286
188906188906Indicated Prevention With At-Risk GamblersCompletedNo Results AvailableGambling|Pathological Gambling|Problem GamblingBehavioral: Personalized Feedback Intervention|Behavioral: Cognitive Behavioral Interventionhttps://ClinicalTrials.gov/show/NCT00078273
188907188907A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: pemetrexedhttps://ClinicalTrials.gov/show/NCT00078260
188908188908Anti-HIV Drugs for Ugandan Patients With HIV and TuberculosisCompletedNo Results AvailableHIV Infections|TuberculosisDrug: Abacavir|Drug: Lamivudine|Drug: Zidovudine|Drug: Tuberculosis treatmenthttps://ClinicalTrials.gov/show/NCT00078247
188909188909Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic LeukemiaCompletedNo Results AvailableChronic Lymphocytic LeukemiaDrug: Oblimersen-rituximab-fludarabinehttps://ClinicalTrials.gov/show/NCT00078234
188910188910Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)Active, not recruitingNo Results AvailableMacular DegenerationDevice: Rheopheresis blood filtrationhttps://ClinicalTrials.gov/show/NCT00078221
188881188881A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: Antegren(TM) (natalizumab)https://ClinicalTrials.gov/show/NCT00078611
188882188882A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's LymphomaRecruitingNo Results AvailableNon-Hodgkin's LymphomaDrug: Rituximab or Iodine I 131 Tositumomab Therapyhttps://ClinicalTrials.gov/show/NCT00078598
188883188883PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyActive, not recruitingNo Results AvailableProstate CancerBiological: PROSTVAC®-VF/TRICOM™https://ClinicalTrials.gov/show/NCT00078585
188884188884Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: capecitabine|Drug: lapatinib (GW572016)https://ClinicalTrials.gov/show/NCT00078572
188885188885Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in AdultsCompletedHas ResultsKidney Transplantation|Kidney DiseaseDrug: Alemtuzumab|Drug: Sirolimus|Drug: Tacrolimus|Procedure: Kidney transplant|Drug: Methylprednisolone (or equivalent)|Drug: Acetaminophen|Drug: Diphenhydramine|Drug: Trimethoprim (TMP)/Sulfa (Bactrim, Septra)|Drug: Valgancyclovir|Drug: Acyclovir|Drug: Pentamidine|Drug: Clotrimazole|Drug: Nystatinhttps://ClinicalTrials.gov/show/NCT00078559
188886188886EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)CompletedNo Results AvailableNasopharyngeal Cancer|EBV InfectionsBiological: EBV specific CTL Infusion|Biological: Anti CD45 monoclonal antibodyhttps://ClinicalTrials.gov/show/NCT00078546
188887188887Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell TransplantCompletedNo Results AvailableCytomegalovirus InfectionsBiological: CMV CTL infusionhttps://ClinicalTrials.gov/show/NCT00078533
188888188888Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor CellsCompletedNo Results AvailableLeukemia|Leukemia, B-Cell, ChronicBiological: IL-2 AND HUMAN CD40 LIGAND PLASMID GENE MODIFIED AUTOLOGOUS TUMOR CELLShttps://ClinicalTrials.gov/show/NCT00078520
188889188889Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal DisharmonyCompletedNo Results AvailableMandibular AdvancementBehavioral: Sensory Re-training|Behavioral: Sensory Retraining|Behavioral: Opening Exerciseshttps://ClinicalTrials.gov/show/NCT00078507
188890188890Peptide Vaccine to Prevent Recurrence of Nasopharyngeal CancerCompletedNo Results AvailableNasopharyngeal NeoplasmsDrug: EBV-LMP-2https://ClinicalTrials.gov/show/NCT00078494
188891188891Phase 1 Trial of Idebenone to Treat Patients With Friedreich's AtaxiaCompletedNo Results AvailableFriedreich AtaxiaDrug: Idebenonehttps://ClinicalTrials.gov/show/NCT00078481
188892188892Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed TreatmentCompletedNo Results AvailableColorectal NeoplasmsDrug: PELITREXOL/AG-2037https://ClinicalTrials.gov/show/NCT00078468
188893188893Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CarcinomaCompletedNo Results AvailableNon-Small-Cell Lung CarcinomaDrug: ILX651https://ClinicalTrials.gov/show/NCT00078455
188894188894Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected PeopleCompletedNo Results AvailableHIV InfectionsDrug: Pegylated interferon alfa-2ahttps://ClinicalTrials.gov/show/NCT00078442
188895188895Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHSCompletedNo Results AvailableCoronary Disease|Cardiovascular Diseases|Heart Diseases|Cerebrovascular Accident|Myocardial Infarctionhttps://ClinicalTrials.gov/show/NCT00078429
188896188896Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)CompletedHas ResultsHIV Infections|Hepatitis C|Liver DiseaseDrug: Peginterferon alfa-2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00078403
188897188897Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableNon Small Cell Lung Cancer|Lung Cancer|Stage IIIA Non Small Cell Lung Cancer|Stage IIIB Non Small Cell Lung CancerDrug: S-3304https://ClinicalTrials.gov/show/NCT00078390
188898188898Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With NarcolepsyCompletedHas ResultsNarcolepsyDrug: Armodafinil|Drug: Armodafinil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00078377
188899188899Pain Pathways in the BrainCompletedNo Results AvailableHealthy|Tooth ExtractionProcedure: MRIhttps://ClinicalTrials.gov/show/NCT00078364
188900188900Synvisc to Treat Osteoarthritis of the Temporomandibular JointCompletedNo Results AvailableOsteoarthritisProcedure: High molecular weight hylan (Synvisc) injectionhttps://ClinicalTrials.gov/show/NCT00078351

* Görseller ve İçerik tekif hakkına sahip olabilir